Ideas in this flowchart

• September 2026 FDA cancer decisions expanded care and diagnostic options.
• The FDA had a busy month with new options for several cancers.
• New options addressed breast, lung, kidney, bile duct, skin, and neuroendocrine cancers.
• Some of these cancers previously had few treatment choices.
• A brain tumor scan became available.
• Lung cancer treatment became easier.
• The guide explains each decision, who it is for, and what it could mean for care.
• The previous month's approvals are covered in a separate August 2026 list.